We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Notice for elexacaftor/tezacaftor/ivacaftor (Vertex Pharmaceuticals Australia Pty Ltd)
Active ingredients
elexacaftor/tezacaftor/ivacaftor
Date of review outcome
Lapse date
Type
Orphan drug
Indication
Indicated for the treatment of cystic fibrosis (CF)
Therapeutic area
Respiratory